"Advanced Research Institute is a Multi-Specialty Clinical Trial company that leads the industry in clinical trial conduction. We work with multiple physicians across Northern Utah and Reno, Nevada to bring dozens of clinical trials to your area. At Advanced Research Institute we strive for subject safety, data accuracy, rapid enrollment, and trial integrity."

During the past decade, Advanced Research Institute conducted 51 clinical trials. In the 10-year time frame, 51 clinical trials started and 39 clinical trials were completed, i.e. on average, 76.5% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 23 clinical trials were completed. i.e. 176.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Advanced Research Institute" #1 sponsor was "Allergan" with 8 trials, followed by "Eli Lilly and Company" with 6 trials sponsored, "Shire" with 6 trials sponsored, "Exact Sciences Corporation" with 5 trials sponsored and "Ferring Pharmaceuticals" with 5 trials sponsored. Other sponsors include 44 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Advanced Research Institute" #1 collaborator was "Allergan Sales, LLC" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "RTI Health Solutions" with 2 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Hexal AG" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Advanced Research Institute" are "Colorectal Cancer" (7 trials), "Irritable Bowel Syndrome" (6 trials), "Ulcerative Colitis" (6 trials), "Diabetes Mellitus" (4 trials) and "Diabetes Mellitus, Type 2" (4 trials). Many other conditions were trialed in "Advanced Research Institute" in a lesser frequency.

Most popular intervention types in "Advanced Research Institute" are "Drug" (66 trials), "Other" (5 trials), "Biological" (3 trials), "Device" (3 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "Vonoprazan" (4 trials), "Relamorelin" (3 trials), "APT-1011" (2 trials) and "Asimadoline" (2 trials). Other intervention names were less common.

The vast majority of trials in "Advanced Research Institute" are 75 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Advanced Research Institute". undefined are not yet recruiting, 8 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in Advanced Research Institute, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Advanced Research Institute, 0 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".